Detailed description page of Hmrbase2

This page displays user query in tabular form.

13124 details
Primary information
ID13124
Uniprot IDP01346
DescriptionInsulin-like growth factor II (IGF-II) (Multiplication-stimulating activity) (MSA) (Multiplication-stimulating polypeptide) [Cleaved into- Insulin-like growth factor II; Preptin]
OrganismRattus norvegicus
TxonomyEukaryota; Opisthokonta; Metazoa; Eumetazoa; Bilateria; Deuterostomia; Chordata; Craniata; Vertebrata; Gnathostomata (jawed vertebrates); Teleostomi; Euteleostomi; Sarcopterygii; Dipnotetrapodomorpha; Tetrapoda; Amniota; Mammalia; Theria; Eutheria; Boreoeutheria; Euarchontoglires; Glires (Rodents and rabbits); Rodentia; Myomorpha (mice and others); Muroidea; Muridae; Murinae; Rattus; Rattus norvegicus (Rat)
Subcellular LocationSecreted
Developmental StageNA
SimilarityBelongs to the insulin family.
Tissue SpecificityNA
Post Translational ModificationProteolytically processed by PCSK4; proIGF2 is cleaved at Arg-128 and Arg-92 to generate big-IGF2 and mature IGF2.
FunctionThe insulin-like growth factors possess growth-promoting activity. Major fetal growth hormone in mammals. Plays a key role in regulating fetoplacental development. IGF2 is influenced by placental lactogen. Also involved in tissue differentiation. In adults; involved in glucose metabolism in adipose tissue; skeletal muscle and liver. Acts as a ligand for integrin which is required for IGF2 signaling. Positively regulates myogenic transcription factor MYOD1 function by facilitating the recruitment of transcriptional coactivators; thereby controlling muscle terminal differentiation. Inhibits myoblast differentiation and modulates metabolism via increasing the mitochondrial respiration rate.
Length180
Molecular Weight20
NameInsulin-like growth factor II
SequenceDVSTSQAVLPDDFPRYPVGKFFKFDTWRQSAGRL
Sequence map816
PDB ID6382022; 3889836; 2438416; 3023383; 3167060; 6390212; 3221878; 7016879; 16912056
DrugpediaNA
ReceptorNA
DomainNA
Pharmaceutical UseNA